↑Rual, Jean-François; Venkatesan Kavitha, Hao Tong, Hirozane-Kishikawa Tomoko, Dricot Amélie, Li Ning, Berriz Gabriel F, Gibbons Francis D, Dreze Matija, Ayivi-Guedehoussou Nono, Klitgord Niels, Simon Christophe, Boxem Mike, Milstein Stuart, Rosenberg Jennifer, Goldberg Debra S, Zhang Lan V, Wong Sharyl L, Franklin Giovanni, Li Siming, Albala Joanna S, Lim Janghoo, Fraughton Carlene, Llamosas Estelle, Cevik Sebiha, Bex Camille, Lamesch Philippe, Sikorski Robert S, Vandenhaute Jean, Zoghbi Huda Y, Smolyar Alex, Bosak Stephanie, Sequerra Reynaldo, Doucette-Stamm Lynn, Cusick Michael E, Hill David E, Roth Frederick P, Vidal Marc (Oct. de 2005). «Towards a proteome-scale map of the human protein-protein interaction network». Nature (England) 437 (7062): 1173-8. PMID16189514. doi:10.1038/nature04209.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
↑Zheng, L; Schickling O, Peter M E, Lenardo M J (Aug. de 2001). «The death effector domain-associated factor plays distinct regulatory roles in the nucleus and cytoplasm». J. Biol. Chem. (United States) 276 (34): 31945-52. ISSN0021-9258. PMID11395500. doi:10.1074/jbc.M102799200.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
↑ abSchlisio, Susanne; Halperin Terri, Vidal Miguel, Nevins Joseph R (Nov. de 2002). «Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function». EMBO J. (England) 21 (21): 5775-86. ISSN0261-4189. PMID12411495.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
↑Chen, Deng; Zhang Jianbing, Li Mao, Rayburn Elizabeth R, Wang Hui, Zhang Ruiwen (Feb. de 2009). «RYBP stabilizes p53 by modulating MDM2». EMBO Rep. (England) 10 (2): 166-72. PMID19098711. doi:10.1038/embor.2008.231.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
↑Zhu, J; Shore S K (Dec. de 1996). «c-ABL tyrosine kinase activity is regulated by association with a novel SH3-domain-binding protein». Mol. Cell. Biol. (UNITED STATES) 16 (12): 7054-62. ISSN0270-7306. PMID8943360.